Bioequivalence of Pramipexole Extended Release (PPX ER) 1.5mg x 1 Tablet Once Daily (q.d.) vs. PPX ER 0.375mg x 4 Tablets Under Fasted and Fed Conditions in Japanese Healthy Volunteers
Clinical trial NCT01119443 · COMPLETED
Trial details
- NCT number
- NCT01119443
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-04-01
- Primary completion
- 2010-06-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.